154 related articles for article (PubMed ID: 15218972)
1. Successful micafungin (FK463) treatment of invasive pulmonary aspergillosis in a patient with acute lymphoblastic leukemia in a phase II study.
Ota S; Tanaka J; Kahata K; Toubai T; Kondo K; Mori A; Toyoshima N; Musashi M; Asaka M; Imamura M
Int J Hematol; 2004 May; 79(4):390-3. PubMed ID: 15218972
[TBL] [Abstract][Full Text] [Related]
2. Invasive pulmonary aspergillosis with hematological malignancy caused by Aspergillus terreus and in vitro susceptibility of A. terreus isolate to micafungin.
Tokimatsu I; Kushima H; Iwata A; Hashinaga K; Umeki K; Ohama M; Kohno K; Ishii H; Kishi K; Ogata M; Hiramatsu K; Saikawa T; Kadota J
Intern Med; 2007; 46(11):775-9. PubMed ID: 17541234
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy.
Yokote T; Akioka T; Oka S; Fujisaka T; Yamano T; Hara S; Tsuji M; Hanafusa T
Ann Hematol; 2004 Jan; 83(1):64-6. PubMed ID: 14661114
[TBL] [Abstract][Full Text] [Related]
4. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitis V; Petraitiene R; Groll AH; Roussillon K; Hemmings M; Lyman CA; Sein T; Bacher J; Bekersky I; Walsh TJ
Antimicrob Agents Chemother; 2002 Jun; 46(6):1857-69. PubMed ID: 12019101
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis.
Matsumoto S; Wakai Y; Nakai T; Hatano K; Ushitani T; Ikeda F; Tawara S; Goto T; Matsumoto F; Kuwahara S
Antimicrob Agents Chemother; 2000 Mar; 44(3):619-21. PubMed ID: 10681328
[TBL] [Abstract][Full Text] [Related]
6. [Sucessful treatment by micafungin of pulmonary aspergillosis occurring in an old lung abscess].
Hirata A; Uji M; Matsushita H
Nihon Kokyuki Gakkai Zasshi; 2005 Apr; 43(4):221-4. PubMed ID: 15966368
[TBL] [Abstract][Full Text] [Related]
7. Micafungin: a therapeutic review.
Higashiyama Y; Kohno S
Expert Rev Anti Infect Ther; 2004 Jun; 2(3):345-55. PubMed ID: 15482200
[TBL] [Abstract][Full Text] [Related]
8. [Guidelines for the management of deep mycosis in neutropenic patients].
Yoshida M
Nihon Ishinkin Gakkai Zasshi; 2004; 45(4):209-15. PubMed ID: 15550917
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of pulmonary aspergillosis successfully treated with combinated micafungin and itraconazole therapy].
Furugen M; Haranaga S; Touyama M; Shiroma R; Yara S; Shinzato T; Higa F; Tateyama M; Saitou A; Fujita J
Kansenshogaku Zasshi; 2005 Dec; 79(12):951-6. PubMed ID: 16444977
[TBL] [Abstract][Full Text] [Related]
10. Effective blood concentration of micafungin for pulmonary aspergillosis.
Shimoeda S; Ohta S; Kobayashi H; Yamato S; Sasaki M; Kawano K
Biol Pharm Bull; 2006 Sep; 29(9):1886-91. PubMed ID: 16946503
[TBL] [Abstract][Full Text] [Related]
11. Successful antifungal combination therapy with voriconazole and caspofungin.
Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
[TBL] [Abstract][Full Text] [Related]
12. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.
Denning DW; Marr KA; Lau WM; Facklam DP; Ratanatharathorn V; Becker C; Ullmann AJ; Seibel NL; Flynn PM; van Burik JA; Buell DN; Patterson TF
J Infect; 2006 Nov; 53(5):337-49. PubMed ID: 16678903
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
14. Acute pancreatitis in a patient treated with micafungin.
Sato K; Hayashi M; Utsugi M; Ishizuka T; Takagi H; Mori M
Clin Ther; 2007 Jul; 29(7):1468-73. PubMed ID: 17825698
[TBL] [Abstract][Full Text] [Related]
15. Micafungin, a novel antifungal agent, as empirical therapy in acute leukemia patients with febrile neutropenia.
Yanada M; Kiyoi H; Murata M; Suzuki M; Iwai M; Yokozawa T; Baba H; Emi N; Naoe T
Intern Med; 2006; 45(5):259-64. PubMed ID: 16595990
[TBL] [Abstract][Full Text] [Related]
16. Micafungin.
Jarvis B; Figgitt DP; Scott LJ
Drugs; 2004; 64(9):969-82; discussion 983-4. PubMed ID: 15101786
[TBL] [Abstract][Full Text] [Related]
17. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
18. The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.
Wiederhold NP; Lewis JS
Expert Opin Pharmacother; 2007 Jun; 8(8):1155-66. PubMed ID: 17516879
[TBL] [Abstract][Full Text] [Related]
19. Role of micafungin in the antifungal armamentarium.
Ikeda F; Tanaka S; Ohki H; Matsumoto S; Maki K; Katashima M; Barrett D; Aoki Y
Curr Med Chem; 2007; 14(11):1263-75. PubMed ID: 17504145
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary aspergillosis in the neutropenic patient. Apropos of 4 cases].
Ben Othman T; Ben Lakhal B; Medini Manai Z; Ladeb S; M'Sadek F; Meddeb B; Ben Abid H; Bel Hadj Ali Z; Hafsia R; Ben Abdeladhim A; Hafsia A
Tunis Med; 1996 Nov; 74(11):493-500. PubMed ID: 9506113
[No Abstract] [Full Text] [Related]
[Next] [New Search]
